{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:10Z","timestamp":1792784230673,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T00:00:00Z","timestamp":1472774400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PEst-C\/SAU\/LA0001\/2013-2014"],"award-info":[{"award-number":["PEst-C\/SAU\/LA0001\/2013-2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/NEU\/04539\/2013"],"award-info":[{"award-number":["UID\/NEU\/04539\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/SAU-FCF\/108056\/2008"],"award-info":[{"award-number":["PTDC\/SAU-FCF\/108056\/2008"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["EXPL\/BIM-MEC\/2220\/2013"],"award-info":[{"award-number":["EXPL\/BIM-MEC\/2220\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/86655\/2012 (fellowship)"],"award-info":[{"award-number":["SFRH\/BD\/86655\/2012 (fellowship)"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/44246\/2008 (fellowship)"],"award-info":[{"award-number":["SFRH\/BPD\/44246\/2008 (fellowship)"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BPD\/91811\/2012 (fellowship)"],"award-info":[{"award-number":["SFRH\/BPD\/91811\/2012 (fellowship)"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Santa Casa da Miseric\u00f3rdia de Lisboa (SCML), Portugal","award":["Mantero Belard Neuroscience prize 2013"],"award-info":[{"award-number":["Mantero Belard Neuroscience prize 2013"]}],"id":[{"id":"https:\/\/ror.org\/00dx9kg40","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12035-016-0048-3","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T03:37:28Z","timestamp":1472787448000},"page":"5385-5399","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington\u2019s Disease Models"],"prefix":"10.1007","volume":"54","author":[{"given":"Luana","family":"Naia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana R.","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia I.","family":"Oliveira-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys L.","family":"Caldeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio N.","family":"La\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina R.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0700-3776","authenticated-orcid":false,"given":"A. Cristina","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,2]]},"reference":[{"key":"48_CR1","doi-asserted-by":"publisher","first-page":"14178","DOI":"10.1073\/pnas.250422697","volume":"97","author":"KG Tanner","year":"2000","unstructured":"Tanner KG, Landry J, Sternglanz R, Denu JM (2000) Silent information regulator 2 family of NAD-dependent histone\/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci U S A 97:14178\u201314182. doi: 10.1073\/pnas.250422697","journal-title":"Proc Natl Acad Sci U S A"},{"key":"48_CR2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nrm3841","volume":"15","author":"C Choudhary","year":"2014","unstructured":"Choudhary C, Weinert BT, Nishida Y, et al. (2014) The growing landscape of lysine acetylation links metabolism and cell signalling. Nat Rev Mol Cell Biol 15:536\u2013550. doi: 10.1038\/nrm3841","journal-title":"Nat Rev Mol Cell Biol"},{"key":"48_CR3","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","volume":"27","author":"JM Gil","year":"2008","unstructured":"Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington\u2019s disease. Eur J Neurosci 27:2803\u20132820. doi: 10.1111\/j.1460-9568.2008.06310.x","journal-title":"Eur J Neurosci"},{"key":"48_CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1515\/rns.2011.060","volume":"23","author":"L Naia","year":"2011","unstructured":"Naia L, Ribeiro MJ, Rego AC (2011) Mitochondrial and metabolic-based protective strategies in Huntington\u2019s disease: the case of creatine and coenzyme Q. Rev Neurosci 23:13\u201328","journal-title":"Rev Neurosci"},{"key":"48_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","volume":"231","author":"IL Ferreira","year":"2011","unstructured":"Ferreira IL, Cunha-Oliveira T, Nascimento MV, et al. (2011) Bioenergetic dysfunction in Huntington\u2019s disease human cybrids. Exp Neurol 231:127\u2013134. doi: 10.1016\/j.expneurol.2011.05.024","journal-title":"Exp Neurol"},{"key":"48_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.mito.2013.05.006","volume":"13","author":"AC Silva","year":"2013","unstructured":"Silva AC, Almeida S, La\u00e7o M, et al. (2013) Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic huntington\u2019s disease carriers. Mitochondrion 13:801\u2013809. doi: 10.1016\/j.mito.2013.05.006","journal-title":"Mitochondrion"},{"key":"48_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12035-014-8735-4","volume":"51","author":"L Naia","year":"2015","unstructured":"Naia L, Ferreira IL, Cunha-Oliveira T, et al. (2015) Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington\u2019s disease human lymphoblasts. Mol Neurobiol 51:331\u2013348. doi: 10.1007\/s12035-014-8735-4","journal-title":"Mol Neurobiol"},{"key":"48_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/ng1534","volume":"37","author":"JA Parker","year":"2005","unstructured":"Parker JA, Arango M, Abderrahmane S, et al. (2005) Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 37:349\u2013350. doi: 10.1038\/ng1534","journal-title":"Nat Genet"},{"key":"48_CR9","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","volume":"17","author":"J Pallos","year":"2008","unstructured":"Pallos J, Bodai L, Lukacsovich T, et al. (2008) Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington\u2019s disease. Hum Mol Genet 17:3767\u20133775. doi: 10.1093\/hmg\/ddn273","journal-title":"Hum Mol Genet"},{"key":"48_CR10","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.bbadis.2015.07.003","volume":"1852","author":"L Naia","year":"2015","unstructured":"Naia L, Rego AC (2015) Sirtuins: double players in Huntington\u2019s disease. Biochim Biophys Acta - Mol Basis Dis 1852:2183\u20132194. doi: 10.1016\/j.bbadis.2015.07.003","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"48_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nm.2558","volume":"18","author":"M Jiang","year":"2012","unstructured":"Jiang M, Wang J, Fu J, et al. (2012) Neuroprotective role of Sirt1 in mammalian models of Huntington\u2019s disease through activation of multiple Sirt1 targets. Nat Med 18:153\u2013158. doi: 10.1038\/nm.2558","journal-title":"Nat Med"},{"key":"48_CR12","doi-asserted-by":"publisher","first-page":"e0145425","DOI":"10.1371\/journal.pone.0145425","volume":"11","author":"R Tulino","year":"2016","unstructured":"Tulino R, Benjamin AC, Jolinon N, et al. (2016) SIRT1 activity is linked to its brain region-specific phosphorylation and is impaired in Huntington\u2019s disease mice. PLoS One 11:e0145425. doi: 10.1371\/journal.pone.0145425","journal-title":"PLoS One"},{"key":"48_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.expneurol.2010.05.006","volume":"225","author":"DJ Ho","year":"2010","unstructured":"Ho DJ, Calingasan NY, Wille E, et al. (2010) Resveratrol protects against peripheral deficits in a mouse model of Huntington\u2019s disease. Exp Neurol 225:74\u201384. doi: 10.1016\/j.expneurol.2010.05.006","journal-title":"Exp Neurol"},{"key":"48_CR14","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","volume":"15","author":"NL Price","year":"2012","unstructured":"Price NL, Gomes AP, Ling AJY, et al. (2012) SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15:675\u2013690. doi: 10.1016\/j.cmet.2012.04.003","journal-title":"Cell Metab"},{"key":"48_CR15","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1231097","volume":"339","author":"BP Hubbard","year":"2013","unstructured":"Hubbard BP, Gomes AP, Dai H, et al. (2013) Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 339:1216\u20131219. doi: 10.1126\/science.1231097","journal-title":"Science"},{"key":"48_CR16","doi-asserted-by":"publisher","first-page":"17187","DOI":"10.1074\/jbc.M501250200","volume":"280","author":"MT Borra","year":"2005","unstructured":"Borra MT, Smith BC, Denu JM (2005) Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 280:17187\u201317195. doi: 10.1074\/jbc.M501250200","journal-title":"J Biol Chem"},{"key":"48_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature01965.1","volume":"425","author":"K Howitz","year":"2003","unstructured":"Howitz K, Bitterman J, Cohen H (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191\u2013196. doi: 10.1038\/nature01965.1","journal-title":"Nature"},{"key":"48_CR18","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","volume":"127","author":"M Lagouge","year":"2006","unstructured":"Lagouge M, Argmann C, Gerhart-Hines Z, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109\u20131122. doi: 10.1016\/j.cell.2006.11.013","journal-title":"Cell"},{"key":"48_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cmet.2008.06.011","volume":"8","author":"KJ Pearson","year":"2008","unstructured":"Pearson KJ, Baur JA, Lewis KN, et al. (2008) Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8:157\u2013168. doi: 10.1016\/j.cmet.2008.06.011","journal-title":"Cell Metab"},{"key":"48_CR20","doi-asserted-by":"publisher","first-page":"50985","DOI":"10.1074\/jbc.M306552200","volume":"278","author":"MD Jackson","year":"2003","unstructured":"Jackson MD, Schmidt MT, Oppenheimer NJ, Denu JM (2003) Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone\/protein deacetylases. J Biol Chem 278:50985\u201350998. doi: 10.1074\/jbc.M306552200","journal-title":"J Biol Chem"},{"key":"48_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nbt.3130","volume":"33","author":"C Scholz","year":"2015","unstructured":"Scholz C, Weinert BT, Wagner SA, et al. (2015) Acetylation site specificities of lysine deacetylase inhibitors in human cells. Nat Biotech 33:415\u2013423. doi: 10.1038\/nbt.3130","journal-title":"Nat Biotech"},{"key":"48_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nbd.2010.08.017","volume":"41","author":"T Hathorn","year":"2011","unstructured":"Hathorn T, Snyder-Keller A, Messer A (2011) Nicotinamide improves motor deficits and upregulates PGC-1\u03b1 and BDNF gene expression in a mouse model of Huntington\u2019s disease. Neurobiol Dis 41:43\u201350. doi: 10.1016\/j.nbd.2010.08.017","journal-title":"Neurobiol Dis"},{"key":"48_CR23","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/hmg\/ddh214","volume":"13","author":"S Ghosh","year":"2004","unstructured":"Ghosh S, Feany MB (2004) Comparison of pathways controlling toxicity in the eye and brain in drosophila models of human neurodegenerative diseases. Hum Mol Genet 13:2011\u20132018. doi: 10.1093\/hmg\/ddh214","journal-title":"Hum Mol Genet"},{"key":"48_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nchembio.1352","volume":"9","author":"K Schmeisser","year":"2013","unstructured":"Schmeisser K, Mansfeld J, Kuhlow D, et al. (2013) Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. Nat Chem Biol 9:693\u2013700. doi: 10.1038\/nchembio.1352","journal-title":"Nat Chem Biol"},{"key":"48_CR25","doi-asserted-by":"publisher","unstructured":"Naia L, Ribeiro M, Rodrigues J, et al. (2016) Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin. Neuropeptides:1\u20139. doi: 10.1016\/j.npep.2016.01.009","DOI":"10.1016\/j.npep.2016.01.009"},{"key":"48_CR26","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, et al. (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12:1555\u20131567. doi: 10.1093\/hmg\/ddg169","journal-title":"Hum Mol Genet"},{"key":"48_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.oraloncology.2009.10.007","volume":"46","author":"GN Berta","year":"2010","unstructured":"Berta GN, Salamone P, Sprio AE, et al. (2010) Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of resveratrol complexed with 2-hydroxypropyl-beta-cyclodextrin. Oral Oncol 46:42\u201348. doi: 10.1016\/j.oraloncology.2009.10.007","journal-title":"Oral Oncol"},{"key":"48_CR28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/0975-7406.67003","volume":"2","author":"G Tiwari","year":"2010","unstructured":"Tiwari G, Tiwari R, Rai AK (2010) Cyclodextrins in delivery systems: applications. J Pharm Bioallied Sci 2:72\u201379. doi: 10.4103\/0975-7406.67003","journal-title":"J Pharm Bioallied Sci"},{"key":"48_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-1-61779-504-6_22","volume":"837","author":"V Venegas","year":"2012","unstructured":"Venegas V, Halberg MC (2012) Measurement of mitochondrial DNA copy number. Methods Mol Biol 837:327\u2013335. doi: 10.1007\/978-1-61779-504-6_22","journal-title":"Methods Mol Biol"},{"key":"48_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0006-3495(99)77214-0","volume":"76","author":"RC Scaduto","year":"1999","unstructured":"Scaduto RC, Grotyohann LW (1999) Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J 76:469\u2013477. doi: 10.1016\/S0006-3495(99)77214-0","journal-title":"Biophys J"},{"key":"48_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.molcel.2004.08.031","volume":"16","author":"A Vaquero","year":"2004","unstructured":"Vaquero A, Scher M, Lee D, et al. (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 16:93\u2013105. doi: 10.1016\/j.molcel.2004.08.031","journal-title":"Mol Cell"},{"key":"48_CR32","doi-asserted-by":"publisher","first-page":"0344","DOI":"10.1371\/journal.pgen.0020040","volume":"2","author":"K Pruitt","year":"2006","unstructured":"Pruitt K, Zinn RL, Ohm JE, et al. (2006) Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet 2:0344\u20130352. doi: 10.1371\/journal.pgen.0020040","journal-title":"PLoS Genet"},{"key":"48_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cell.2008.07.002","volume":"134","author":"Y Nakahata","year":"2008","unstructured":"Nakahata Y, Kaluzova M, Grimaldi B, et al. (2008) The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134:329\u2013340. doi: 10.1016\/j.cell.2008.07.002","journal-title":"Cell"},{"key":"48_CR34","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1073\/pnas.1217632110","volume":"110","author":"S Masri","year":"2013","unstructured":"Masri S, Patel VR, Eckel-Mahan KL, et al. (2013) Circadian acetylome reveals regulation of mitochondrial metabolic pathways. Proc Natl Acad Sci 110:3339\u20133344. doi: 10.1073\/pnas.1217632110","journal-title":"Proc Natl Acad Sci"},{"key":"48_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.expneurol.2009.05.012","volume":"219","author":"J Sassone","year":"2009","unstructured":"Sassone J, Colciago C, Cislaghi G, et al. (2009) Huntington\u2019s disease: the current state of research with peripheral tissues. Exp Neurol 219:385\u2013397. doi: 10.1016\/j.expneurol.2009.05.012","journal-title":"Exp Neurol"},{"key":"48_CR36","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/embor.2011.151","volume":"12","author":"LG Noriega","year":"2011","unstructured":"Noriega LG, Feige JN, Canto C, et al. (2011) CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability. EMBO Rep 12:1069\u20131076. doi: 10.1038\/embor.2011.151","journal-title":"EMBO Rep"},{"key":"48_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, et al. (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127:59\u201369. doi: 10.1016\/j.cell.2006.09.015","journal-title":"Cell"},{"key":"48_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-1326-6-32","volume":"6","author":"E Taherzadeh-Fard","year":"2011","unstructured":"Taherzadeh-Fard E, Saft C, Akkad DA, et al. (2011) PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease. Mol Neurodegener 6:32. doi: 10.1186\/1750-1326-6-32","journal-title":"Mol Neurodegener"},{"key":"48_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt P, Pineda VV, Torrence AE, et al. (2006) Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration. Cell Metab 4:349\u2013362. doi: 10.1016\/j.cmet.2006.10.004","journal-title":"Cell Metab"},{"key":"48_CR40","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1038\/ncomms4077","volume":"5","author":"HB Ngo","year":"2014","unstructured":"Ngo HB, Lovely GA, Phillips R, Chan DC (2014) Distinct structural features of TFAM drive mitochondrial DNA packaging versus transcriptional activation. Nat Commun 5:3077. doi: 10.1038\/ncomms4077","journal-title":"Nat Commun"},{"key":"48_CR41","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","volume":"25","author":"JM Van Raamsdonk","year":"2005","unstructured":"Van Raamsdonk JM, Pearson J, Slow EJ, et al. (2005) Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington\u2019s disease. J Neurosci 25:4169\u20134180. doi: 10.1523\/JNEUROSCI.0590-05.2005","journal-title":"J Neurosci"},{"key":"48_CR42","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/01688638408401231","volume":"6","author":"J Brandt","year":"1984","unstructured":"Brandt J, Strauss ME, Larus J, et al. (1984) Clinical correlates of dementia and disability in Huntington\u2019s disease. J Clin Neuropsychol 6:401\u2013412. doi: 10.1080\/01688638408401231","journal-title":"J Clin Neuropsychol"},{"key":"48_CR43","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, et al. (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet 20:1438\u20131455. doi: 10.1093\/hmg\/ddr024","journal-title":"Hum Mol Genet"},{"key":"48_CR44","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/acn3.135","volume":"1","author":"M Jiang","year":"2014","unstructured":"Jiang M, Zheng J, Peng Q, et al. (2014) Sirtuin 1 activator SRT2104 protects Huntington\u2019s disease mice. Ann Clin Transl Neurol 1:1047\u20131052. doi: 10.1002\/acn3.135","journal-title":"Ann Clin Transl Neurol"},{"key":"48_CR45","doi-asserted-by":"publisher","first-page":"8340","DOI":"10.1074\/jbc.M109.088682","volume":"285","author":"M Pacholec","year":"2010","unstructured":"Pacholec M, Bleasdale JE, Chrunyk B, et al. (2010) SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 285:8340\u20138351. doi: 10.1074\/jbc.M109.088682","journal-title":"J Biol Chem"},{"key":"48_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493\u2013506. doi: 10.1038\/nrd2060","journal-title":"Nat Rev Drug Discov"},{"key":"48_CR47","first-page":"675","volume":"294","author":"LV Hankes","year":"1991","unstructured":"Hankes LV, Coenen HH, Rota E, et al. (1991) Effect of Huntington\u2019s and Alzheimer\u2019s diseases on the transport of nicotinic acid or nicotinamide across the human blood-brain barrier. AdvExpMedBiol 294:675\u2013678","journal-title":"AdvExpMedBiol"},{"key":"48_CR48","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature05354","volume":"444","author":"JA Baur","year":"2006","unstructured":"Baur JA, Pearson KJ, Price NL, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337\u2013342. doi: 10.1038\/nature05354","journal-title":"Nature"},{"key":"48_CR49","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst CA, Leavitt BR, et al. (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5:731\u2013736. doi: 10.1038\/nn884","journal-title":"Nat Neurosci"},{"key":"48_CR50","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nn.3721","volume":"17","author":"H Yano","year":"2014","unstructured":"Yano H, Baranov SV, Baranova OV, et al. (2014) Inhibition of mitochondrial protein import by mutant huntingtin. Nat Neurosci 17:822\u2013831. doi: 10.1038\/nn.3721","journal-title":"Nat Neurosci"},{"key":"48_CR51","doi-asserted-by":"publisher","DOI":"10.5772\/32728","author":"T Cunha-Oliveira","year":"2012","unstructured":"Cunha-Oliveira T, Lusa I, Cristina A (2012) Consequences of mitochondrial dysfunction in Huntington\u2019s disease and protection via phosphorylation pathways. Huntington\u2019s Dis - Core Concepts Curr Adv. doi: 10.5772\/32728","journal-title":"Huntington\u2019s Dis - Core Concepts Curr Adv"},{"key":"48_CR52","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.bbamcr.2010.09.019","volume":"1813","author":"RC Scarpulla","year":"2011","unstructured":"Scarpulla RC (2011) Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta 1813:1269\u20131278. doi: 10.1016\/j.bbamcr.2010.09.019","journal-title":"Biochim Biophys Acta"},{"key":"48_CR53","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1093\/hmg\/ddt603","volume":"23","author":"A Lopes costa","year":"2014","unstructured":"Lopes costa A, Le bachelier C, Mathieu L, et al. (2014) Beneficial effects of resveratrol on respiratory chain defects in patients\u2019 fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling. Hum Mol Genet 23:2106\u20132119. doi: 10.1093\/hmg\/ddt603","journal-title":"Hum Mol Genet"},{"key":"48_CR54","doi-asserted-by":"publisher","first-page":"45099","DOI":"10.1074\/jbc.M205670200","volume":"277","author":"KJ Bitterman","year":"2002","unstructured":"Bitterman KJ, Anderson RM, Cohen HY, et al. (2002) Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast Sir2 and human SIRT1. J Biol Chem 277:45099\u201345107. doi: 10.1074\/jbc.M205670200","journal-title":"J Biol Chem"},{"key":"48_CR55","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1124\/jpet.107.120758.energy","volume":"324","author":"AA Sauve","year":"2008","unstructured":"Sauve AA (2008) NAD+ and vitamin B 3\u202f: from metabolism to therapies. J Pharmacol Exp Ther 324:883\u2013893. doi: 10.1124\/jpet.107.120758.energy","journal-title":"J Pharmacol Exp Ther"},{"key":"48_CR56","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000072668","volume":"69","author":"L Klaidman","year":"2003","unstructured":"Klaidman L, Morales M, Kem S, et al. (2003) Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function. Pharmacology 69:150\u2013157. doi: 10.1159\/000072668","journal-title":"Pharmacology"},{"key":"48_CR57","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2174\/156720205774322584","volume":"2","author":"ZZ Chong","year":"2005","unstructured":"Chong ZZ, Lin SH, Li F, Maiese K (2005) The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through AKT, BAD, PARP, and mitochondrial associated \u201canti-apoptotic\u201d pathways. Curr Neurovasc Res 2:271\u2013285. doi: 10.2174\/156720205774322584","journal-title":"Curr Neurovasc Res"},{"key":"48_CR58","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12017-009-8058-1","volume":"11","author":"D Liu","year":"2009","unstructured":"Liu D, Gharavi R, Pitta M, et al. (2009) Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by sirt1 may endanger energetically compromised neurons. Neruomol Med 11:28\u201342. doi: 10.1007\/s12017-009-8058-1","journal-title":"Neruomol Med"},{"key":"48_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019881","author":"O Vang","year":"2011","unstructured":"Vang O, Ahmad N, Baile CA, et al. (2011) What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One. doi: 10.1371\/journal.pone.0019881","journal-title":"PLoS One"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-0048-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0048-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0048-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-0048-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T11:47:17Z","timestamp":1657194437000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-0048-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,2]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["48"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-0048-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,2]]}}}